Home > News > Biotechnology companies learn how to attract more VC
March 17th, 2005
Biotechnology companies learn how to attract more VC
Christopher Anzalone, founder and CEO of The Benet Group in Washington, D.C., said the investment group looks for promising technology over all else. Nanotechnology looks particularly promising, with the federal government putting upward of a billion dollars into nanotech research annually.
But Bonsal said using public money to finance nanotech is probably premature. He cited NanoInk, a Chicago company formerly headed by Anzalone, which issued an initial public offering only to later withdraw it due to lack of interest. "There's capital," Anzalone said. "What's missing is good companies."
Arrowhead to Present at Barclays Global Healthcare Conference March 11th, 2014
Nano Labs Shareholder Update March 8th, 2014
FEI Company Announces Date for Investor Conference Participation March 3rd, 2014
Industrial Nanotech, Inc. Completes On Site Visit by PCAOB Audit Firm - Nears Completion of Audit in Preparation for Move to a Senior Stock Exchange in Late 2014 February 27th, 2014